Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.22.1
Equity (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of stock options outstanding
Options Outstanding     Options Exercisable  
Range of
Exercise
Price
    Number
Outstanding at
March 31, 2022
    Weighted Average
Remaining
Contractual Life
(Years)
    Weighted
Average
Exercise
Price
    Number
Exercisable at
March 31, 2022
    Weighted
Average
Exercise
Price
 
$ 0.50 – 0.82       2,460,000       4.84     $ 0.56       2,116,667     $ 0.52  
  1.00 – 1.93       2,955,000       4.55       1.39       2,845,000       1.40  
  2.00 – 2.80       2,740,000       1.52       2.17       2,740,000       2.17  
  4.76       30,000       2.01       4.76       30,000       4.76  
$ 0.50 – 4.76       8,185,000       3.62     $ 1.41       7,731,667     $ 1.44  

 

Schedule of stock option activities
    Number of Options     Weighted
Average
Exercise
Price
 
Outstanding at January 1, 2022     7,725,000     $ 1.45  
Granted     460,000       0.82  
Expired/forfeited/exercised    
-
     
-
 
Outstanding at March 31, 2022     8,185,000     $ 1.41  
Options exercisable at March 31, 2022     7,731,667     $ 1.44  
Options expected to vest     453,333     $ 0.87  

 

Schedule of company’s nonvested stock options granted
    Number of
Options
    Weighted
Average
Exercise
Price
 
Nonvested at January 1, 2022     205,834     $ 1.04  
Granted     460,000       0.82  
Vested     (212,501 )     (0.91 )
Nonvested at March 31, 2022     453,333     $ 0.87